Transformation of an Unclassified Myeloproliferative Neoplasm with a Rare BCR-JAK2 Fusion Transcript Resulting from the Translocation (9;22)(p24;q11)
BCR-ABL1 negative myeloproliferative neoplasms (MPNs) are known to contain alterations of the tyrosine kinase JAK2 (located on 9p24) that result in constitutive activation of the encoded protein. JAK2 fusions are reported in acute and chronic leukemias of myeloid and lymphoid phenotypes. Here, we re...
Main Authors: | A. N. Chamseddine, P. Etancelin, D. Penther, F. Parmentier, C. Kuadjovi, V. Camus, N. Contentin, P. Lenain, C. Bastard, H. Tilly, F. Jardin |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2015-01-01
|
Series: | Case Reports in Hematology |
Online Access: | http://dx.doi.org/10.1155/2015/252537 |
Similar Items
-
MYELOPROLIFERATIVE NEOPLASMS WITH CONCURRENT BCR-ABL FUSION GENE AND JAK2V617F MUTATION
by: Roxana Popescu, et al.
Published: (2014-12-01) -
Allelic expression imbalance of JAK2 V617F mutation in BCR-ABL negative myeloproliferative neoplasms.
by: Hye-Ran Kim, et al.
Published: (2013-01-01) -
Efficacy of ruxolitinib in a patient with myelodysplastic/myeloproliferative neoplasm unclassifiable and co-mutated JAK2, SF3B1 and TP53
by: Qian Wang, et al.
Published: (2020-01-01) -
BCR-JAK2 fusion as a result of a translocation (9;22)(p24;q11.2) in a patient with CML-like myeloproliferative disease
by: Elnaggar Mohamed M, et al.
Published: (2012-05-01) -
The frequency of calreticulin and mpl gene mutations in bcr-abl and jak2 unmutated chronic myeloproliferative neoplasms and its effect on the outcome
by: T. Tiryaki, et al.
Published: (2020-10-01)